Nicola Boffini

3PUBLICATIONS
16CO-AUTHORS
PharmacogenomicsAutoimmunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jun 04, 2024
Retention rates of different Janus kinase inhibitors in rheumatoid arthritis: experience from a large monocentric cohort.

N Farina, A Tomelleri, N Boffini

|Mar 20, 2024
Secukinumab is not associated with cancer recurrence or progression in patients with spondyloarthritis and history of neoplastic disease.

Nicola Farina, Alessandro Tomelleri, Nicola Boffini

|Aug 01, 2023
Safety of Janus Kinase Inhibitors: A Real-World Multicenter Retrospective Cohort Study.

Marco Lanzillotta, Nicola Boffini, Elisa Barone

Pageof 1

Frequent Collaborators

3 joint publications

Lorenzo Dagna

2 joint publications

Nicola Farina

2 joint publications

Alessandro Tomelleri

2 joint publications

Stefania Calvisi

2 joint publications

Elena Baldissera

2 joint publications

Marco Matucci-Cerinic

1 joint publications

Marco Lanzillotta

1 joint publications

Elisa Barone

1 joint publications

Gilberto Cincinelli

1 joint publications

Maria C Gerardi

Frequent Collaborators

3 joint publications

Lorenzo Dagna

2 joint publications

Nicola Farina

2 joint publications

Alessandro Tomelleri

2 joint publications

Stefania Calvisi

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

1.1K
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on : Apr 22, 2019

11.5K
See more related videos

Top Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

1.1K
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on : Apr 22, 2019

11.5K
See more related videos